August 16, 2012
Astellas Pharma and AstraZeneca K.K. (AZ) announced on August 10 that Symbicort Turbuhaler (budesonide + formoterol fumarate hydrate), a dry powder combination inhaler, has been approved for the additional indication for the relief of various symptoms of chronic obstructive pulmonary...read more